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Staphylococcus haemolyticus is a skin commensal gaining increased attention as an
emerging pathogen of nosocomial infections. However, knowledge about the transition
from a commensal to an invasive lifestyle remains sparse and there is a paucity of
studies comparing pathogenicity traits between commensal and clinical isolates. In
this study, we used a pan-genomic approach to identify factors important for infection
and hospital adaptation by exploring the genomic variability of 123 clinical isolates
and 46 commensal S. haemolyticus isolates. Phylogenetic reconstruction grouped
the 169 isolates into six clades with a distinct distribution of clinical and commensal
isolates in the different clades. Phenotypically, multi-drug antibiotic resistance was
detected in 108/123 (88%) of the clinical isolates and 5/46 (11%) of the commensal
isolates (p < 0.05). In the clinical isolates, we commonly identified a homolog of the
serine-rich repeat glycoproteins sraP. Additionally, three novel capsular polysaccharide
operons were detected, with a potential role in S. haemolyticus virulence. Clinical
S. haemolyticus isolates showed specific signatures associated with successful hospital
adaption. Biofilm forming S. haemolyticus isolates that are resistant to oxacillin (mecA)
and aminoglycosides (aacA-aphD) are most likely invasive isolates whereas absence of
these traits strongly indicates a commensal isolate. We conclude that our data show
a clear segregation of isolates of commensal origin, and specific genetic signatures
distinguishing the clinical isolates from the commensal isolates. The widespread use of
antimicrobial agents has probably promoted the development of successful hospital
adapted clones of S. haemolyticus clones through acquisition of mobile genetic
elements or beneficial point mutations and rearrangements in surface associated genes.
Keywords: Staphylococcus haemolyticus, pangenome, multidrug resistance, bacterial genomics, pathogenicity,
antibiotic resistance genes
Abbreviations: ARG, antibiotic resistance genes; aSec, accessory secretion system; CARD, comprehensive antibiotic
resistance database; CDS, coding sequence; COG, cluster of orthologous groups; CoNS, coagulase negative staphylococci;
CP, capsule polysaccharide; ENA, European Nucleotide Archive; IS, insertion sequences; MDR, multi drug resistant; Orf,
open reading frame; WGS, whole genome sequence.
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INTRODUCTION
Staphylococcus haemolyticus is an emerging pathogen of
nosocomial infections, and the most frequently isolated
coagulase-negative staphylococcal (CoNS) species alongside
Staphylococcus epidermidis (Hope et al., 2008; Pereira et al., 2014;
Nanoukon et al., 2017; Teeraputon et al., 2017). S. haemolyticus
infections particularly affect immunocompromised patients and
mainly occur as bloodstream and device-associated infections.
Nosocomial S. haemolyticus isolates are ranked as the most
antibiotic resistant species among the CoNS, and antibiotic
therapy choices are therefore very limited (Hope et al., 2008;
Kresken et al., 2011; Barros et al., 2012).
Compared to the more virulent Staphylococcus aureus,
S. haemolyticus possesses few typical virulence factors (Takeuchi
et al., 2005). Formation of biofilm (Fredheim et al., 2009;
Giormezis et al., 2014; Pereira et al., 2014), production of phenol-
soluble modulins (Da et al., 2017) and frequent phenotypic
rearrangements due to a large number of insertion sequences
(IS) (Takeuchi et al., 2005) have been suggested as important
S. haemolyticus virulence determinants. However, these traits
have not yet been linked explicitly to strains of clinical origin. The
oriC environ is a chromosomal region of staphylococci proposed
to be important for the evolution and differentiation of each
staphylococcal species. There is little homology between the oriC
environ of the different staphylococcal species, and the region
does not contain genes essential for viability. The oriC environ
is significantly larger in S. haemolyticus compared to that of
S. aureus and Staphylococcus epidermidis. Moreover, almost half
of the candidate coding sequences (CDS) for virulence are located
within the oriC environ, encoding e.g., surface adhesins and
capsular polysaccharides, factors that can modulate adherence
and contribute to phagocytosis resistance (Takeuchi et al., 2005;
Flahaut et al., 2008).
Despite the advancing clinical relevance of S. haemolyticus,
knowledge about the transition from a commensal to an invasive
lifestyle remains sparse. Moreover, there is a paucity of studies
comparing pathogenicity traits between commensal and clinical
invasive isolates. Predicting invasiveness of staphylococcal strains
by use of marker genes is one approach to differentiate isolates
with different pathogenicity. For S. epidermidis, the ica operon
encoding biofilm formation and the insertion sequence element
IS256; associated with aminoglycoside resistance, have been
proposed as markers for invasive strains of S. epidermidis
(Kozitskaya et al., 2004; Rohde et al., 2004). More recently, Méric
et al. (2018) presented how calculation of a genotype risk score
can predict pathogenicity in S. epidermidis isolates with 80%
accuracy. With the advances in sequencing technologies and
more available bacterial genomes new methods for analysis have
emerged. The total number of genes in a bacterial population,
collectively called the pan-genome, allows identification of genes
more present and important in pathogenic strains (Tettelin
et al., 2005). Studies of S. haemolyticus to date have focused
predominantly on clinical isolates. The aim of this study was to
identify factors important for infection and hospital adaptation
by exploring the genomic variability of clinical and commensal
S. haemolyticus using a pan-genomic approach.
MATERIALS AND METHODS
Bacterial Isolates, Species Identification,
Antibiotic Susceptibility and Biofilm
Testing
This study includes 169 S. haemolyticus isolates; 123 clinical
isolates and 46 commensal isolates. The clinical isolates (mainly
from blood cultures, invasive catheters and wounds), in addition
to five of the commensal isolates, were from different hospital
units and had different geographical origins. They were collected
between 1988 and 2010, and have been described previously
(Cavanagh et al., 2014). The remaining 41 commensal isolates
were skin samples isolated from healthy volunteers with no
antibiotic exposure and no hospitalization or health care
affiliation during the three previous months (Cavanagh et al.,
2016). This was a separate collection from one geographical
location (Tromsø, Norway) and collected between 2013 and
2014 (Cavanagh et al., 2016). An overview of all the isolates
used and their characteristics can be found in Supplementary
Data S1. Species identification was done by 16s rRNA sequencing
and/or matrix-assisted laser desorption ionization time-of-
flight mass spectrometry (MALDI-TOF MS) using a Microflex
LT instrument (Bruker Daltonics, Bremen, Germany), Flex
Control software and the MALDI Biotyper 3.1 software (Bruker
Daltonics, Bremen, Germany). Antibiotic susceptibility testing
was performed as previously described (Cavanagh et al., 2014,
2016), and interpreted according to the 9th version of the
EUCAST guidelines1. Isolates resistant to three or more classes
of antibiotics were classified as multidrug resistant (MDR). Semi-
quantitative determination of biofilm formation was performed
with the modified Christensen assay, as described previously
(Fredheim et al., 2009). Isolates were considered biofilm positive
if they had an optical density (OD) value >0.2 above the
negative control.
Whole Genome Sequencing (WGS),
Assembly and Annotation
The WGS procedure for all clinical isolates and five of
the 46 commensal isolates is described in a previous study
(Cavanagh et al., 2014). For the remaining 41 commensal isolates,
bacterial DNA was extracted and prepared for WGS using
the Wizard Genomic DNA purification kit (Promega, Madison,
United States) according to the manufacturer’s instructions. WGS
was performed on index-tagged libraries for each S. haemolyticus
strain by paired-end sequencing at the Norwegian Sequencing
Centre on an Illumina MiSeq (Illumina Inc., San Diego,
California, United States). Subsequently, all 169 genomes were
(re-assembled using SPAdes version 3.7 software (Bankevich
et al., 2012), with some modification to the default parameters.
Contigs >500 bp were reordered relative to the only complete
fully annotated closed reference genome (JCSC 1435) (Takeuchi
et al., 2005) using ABACAS (version 1.3.1). Protein CDSs were
predicted using Prokka v1.12 (Seemann, 2014) using default
1http://www.eucast.org/
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settings. The sequences are deposited in the European Nucleotide
Archive2; study accession no ERP000943 and ERP114853.
Phylogeny and Molecular Typing
Subtyping of the 169 isolates was performed using kSNP3 to
identify single-nucleotide polymorphisms (SNPs) in the core
genomes and to reconstruct a parsimony phylogenomic tree
(Gardner et al., 2015). Phylogenetic trees were visualized using
the online tool iTol3.
Pan-Genome and Pan-Genome-Wide
Association Study (Pan-GWAS) of
S. haemolyticus
Pan-genome analyses of all 169 isolates were performed using the
Roary software package with default settings (Page et al., 2015).
The program generates a file containing all the predicted gene
clusters and the sequence identifier of each isolate containing
said gene. Based on this file, core, accessory and unique genes
were extracted and saved as individual lists. The accessory list
was subdivided based on clusters common for both clinical and
commensal isolates, in addition to clusters unique to each group.
The unique list was further subdivided based on genes identified
in clinical and commensal isolates. These lists were uploaded to
eggNOG to get cluster of orthologs groups (COG) identifications
(Huerta-Cepas et al., 2016).
Files created by Roary, were used as input for Scoary, a
microbial pan-GWAS tool that calculates the association between
all genes in the accessory genome and traits defined by the users.
For our purpose we only used one trait; whether a given isolate
were of clinical or commensal origin. Based on this information
Scoary reported a list of genes sorted by strength of association
per gene (Brynildsrud et al., 2016).
In silico Analysis and Statistics
The resistance gene identifier in the comprehensive antibiotic
resistance database (CARD; version 1.1.1; Department of
Biochemistry and Biomedical Science; McMaster University,
Canada (Jia et al., 2017) was used to predict genes presumed
to confer antibiotic resistance, and the results were further
compared with the phenotypic susceptibility test results. Potential
virulence factors were identified by homology searches against
the virulence factor database (VFDB) together with putative
virulence factors previously predicted by Takeuchi et al. (2005)
and Chen et al. (2016). Identification of IS elements was
performed using the ISsaga program (Varani et al., 2011). The
presence of IS elements were confirmed by sequence search
against the complete S. haemolyticus sequence collection (both
on contigs and CDS). Sequence coverage of contigs harboring IS
elements was used to quantify the copy numbers: the coverage
of contigs with IS elements divided by the overall average
coverage of its respective genome. Identification of putative
plasmids was performed by screening the genome assemblies
for plasmid replicon (rep) genes using the PlasmidFinder
2www.ebi.ac.uk/ena
3https://itol.embl.de/
database (Carattoli et al., 2014) with coverage settings set to
default of 75%. Identification of prophages, potentially important
for horizontal gene transfer (HGT), was performed by using
PHASTER (Arndt et al., 2016). Plasmid replicon sequences with
more than 80% coverage and predicted intact phages identified
in more than 10 isolates were further investigated by sequence
search in order to confirm the presence of plasmid and phage
genes, respectively.
Data were also analyzed using IBM-SPSS statistical software
(IBM Corp. Released 2015. IBM SPSS Statistics for Windows,
Version 23.0. Armonk, NY: IBM Corp.). Categorical data are
displayed as ratios and frequency (%), and analyzed using
the Chi square test. Pathogenicity is a complex multifactorial
property. We used biological knowledge to identify known
pathogenicity-associated traits enriched in clinical isolates. In
particular, we focused on antibiotic resistance genes (ARGs)
and previously established virulence factors. We developed
different scores including the following four traits; aacA-aphD,
mecA, folP and phenotypic biofilm production. In order to
find a pragmatic score that could differentiate between a
clinical and a commensal isolate we calculated the area under
receiver operating characteristic (ROC) curves, and its 95%
confidence interval.
RESULTS
Genome Composition and Genetic
Variability
The average size of the assembled genomes was 2.52 Mb (2.32–
2.86 Mb), with an average of 120 (32–415) contigs per genome.
Each genome had on average 2,457 (2,239–2,816) predicted
protein sequences (CDSs) with an average GC content of 32%.
The pan-genome of the 169 S. haemolyticus isolate dataset
comprised 9,092 Cluster of Orthologous groups (COGs). We
divided the pan-genome into core genes (genes shared by all
strains), accessory genes (genes shared by some but not all strains)
and unique genes only present in one genome (Figure 1A). The
pan-genome sub-groups were annotated and sorted into COG
categories (Figure 1B). Gene accumulation curves showed that
the core genome plateaued at 1,522 genes reflecting a stable core
and an open pan-genome where the addition of each new genome
increases the total gene pool (Figure 1C).
Thirty-two percent of the annotated genes were categorized
as function unknown, and this class was excluded from the
graphical representation of the COG categories. The most
abundant categories in the core genome were genes involved in
housekeeping functions, like transcription and translation, and
different metabolism categories. The accessory genome had a
larger portion of genes associated with mobile genetic elements
(MGE) such as transposons and bacteriophages (transcription,
replication, recombination and repair (24%), which was also
the most enriched category amongst the unique genes (25.7%).
Genes involved in transcription (12%), genes associated with cell
wall and membrane biogenesis (9.2%) and defense mechanisms
(6.8%) were also considerably more prevalent in the accessory
and unique gene pool, compared to the core gene pool. No
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FIGURE 1 | Staphylococcus haemolyticus pangenome statistics. (A) The size and distribution of the pangenome into the subgroups; core (shared by all isolates),
accessory (shared by some isolates) and unique (found only in one isolate). (B) Collective distribution of core (black), accessory (gray) and unique (white) genes in
COG. (C) Pangenome curve generated by plotting total number of gene families in the pan and core genome.
significant differences of the COG distribution were found
between the clinical and commensal group (data not shown).
Phylogeny and Population Structure
The phylogenetic reconstruction grouped the 169 isolates into
six clades (A–F). There was a distinct distribution of clinical and
commensal isolates into the different clades (Figure 2). The two
largest clades, A and C, consisted almost exclusively of clinical
isolates (88/90; 98%), while the majority of the commensal
isolates (39/46; 85%) were found in clades D and F. The clinical
isolates in clade A–C were more closely related compared to
the commensal isolates. Twenty-eight of 123 (22.8%) clinical
isolates were grouped in the three clades (D–F) predominantly
consisting of commensal isolates. A long branch separating the
“commensal heavy” clade F (78% commensal isolates) from the
rest of the isolates underlines the high variability observed in the
commensal isolates, compared to the clustered clinical isolates
(Figure 2). We observed that with the exception of clade F, the
isolates in all the other clades were closely related, independent
of country of origin. The commensal isolates in clade F, mainly
originating from the same geographic location in Norway, were
in contrast very diverse.
Antibiotic Resistance and Mobile
Genetic Elements (MGE)
Phenotypically, 113/169 (68%) of the isolates were classified as
MDR; 108/123 (88%) of the clinical isolates (Cavanagh et al.,
2014) and 5/46 (11%) of the commensal isolates (Cavanagh
et al., 2016) (p < 0.05). Using a genotypic approach, we
identified the ARGs for most of the observed phenotypes, and
overall, phenotypic and genotypic resistance correlated well.
However, ARGs toward eight additional antibiotic classes were
also detected, but not phenotypically tested (Figure 3).
ARGs were among the most common genes among all
clinical isolates. In particular mecA, aacA/aphD, blaZ were
predominantly found in invasive isolates (Table 1). Phenotypic
macrolide resistance was common in both the commensal (30/46;
65%) and the clinical (100/123; 81%) isolates. However, the
majority of commensal isolates carried the macrolide resistance
gene mphC (28/46; 61%) and few carried ermA (5/46; 11%),
while the clinical isolates had both mphC (75/123; 61%) and
ermC (52/123; 42.3%). The antiseptic resistance genes qacA
and qacB were found in both clinical and commensal isolates,
however qacB was identified predominantly in the commensal
isolates whereas qacA was detected predominantly in clinical
isolates (Figure 3).
For the plasmid analysis, we found a total of 51 replicon
sequences, with an average of 5.5 replicon per clinical isolates
and 7.6 average replicon in commensal isolates. When a
replication sequence was identified in more than 10 isolates,
we examined the presence of the entire plasmid. For smaller
plasmids presence was easily determined, and numbers in
clinical and commensal isolates were calculated and presented
in Table 2. Larger plasmid sequences were often split over
several contigs, thus not all of the plasmid genes were identified.
If the whole plasmid could not be identified, we looked for
the presence of its cargo genes instead. The replicon sequence
of S. haemolyticus plasmid pSHaeB, carrying ermC, was only
found in the clinical isolates (55/123; 45%). The S. aureus
plasmid replicon for pUB110, carrying kanamycin and bleomycin
resistance genes, was identified in 23/123 (19%) clinical and 2/46
(4%) commensal isolates. Chloramphenicol resistance plasmid
pC221 was predicted based on the replicon sequence, and
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FIGURE 2 | (A) Number and origin of isolates included in this study. (B) Phylogenetic tree of the 169 S. haemolyticus isolates, based on SNPs in the core genome.
Each isolate is color coded based on country of origin, as demonstrated in the pie chart. Clinical isolates are displayed as circles and commensal isolates as squares.
FIGURE 3 | (A) Graphical representation of S. haemolyticus antibiotic resistance genotype plotted onto the phylogenetic SNP-based core tree. The figure shows the
presence and absence of ARGs and classes across the different clades. ∗Mutations in gyrA and parC gives resistance to fluoroquinolones. ∗∗ QACs: quaternary
ammonium compounds. (B) The percentage of each ARG present in the clinical and commensal subgroups.
the chloramphenicol gene (cat) was identified in 39 isolates,
all of clinical origin. In addition, the plasmids pSHaeA and
pSHAaeC, the former carrying the fosfomycin resistance gene,
were identified in our collection but in less than 1/3 of all
isolates, and with no clear difference between clinical and
commensal isolates. Several larger plasmids were predicted based
on replicon sequence but none of these were identified in their
entirety. We extracted what we considered interesting cargo
genes from these plasmids and determined the prevalence of
these (Table 3).
We predicted 13 different intact prophages in our collection,
identified in 68% (114/169) of the isolates (clinical 94/123; 76%
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TABLE 1 | Genes and gene versions enriched in 123 clinical isolates, sorted
by significance.














NA SH2607 AtP-binding protein
(plasmid)
76.4 2.2
paaZ SH0090 Bifunctional protein
PaaZ
85.4 13.0












blaZX SH1764 Beta-lactamase 78.1 15.2










fabGX SH0438 FabG 89.4 32.6
NA SH0155 MFS transporter 96.8 47.8
sraPX SH0326 SraP 96.8 47.8









All these genes/gene versions were significantly enriched in clinical isolates
(p < 0.001), the order of presentation from top of the table indicates those with
the lowest p values. X These genes exist in different conserved versions in the
clinical and commensal isolates. SH_ref; S. haemolyticus reference gene numbers
from Takeuchi et al. (2005), accession number AP006716.1. The complete list of
genes can be found in Supplementary Data S2.
and commensal 17/46; 37%). Five of these prophages were found
in more than 10 isolates. The most prevalent phage, exclusively
found in only clinical isolates (63/123; 51%), was predicted
as staphylococcal phage vB_Saus_phi2 and S. aureus phage
StauST398-2. Sequence searches of the two phage genes matched
the same S. haemolyticus genes. Staphylococcus phage SPbeta-
like is a phage of 127,726 bp with 156 CDS, and was identified
in 21 clinical isolates and in one commensal isolate. This phage
carries the genes aacA-aphA and dfrC, encoding resistance to
gentamicin and trimethoprim, in addition to five IS256 and one
IS431 element (CDS 146–156). Of all the isolates carrying this
TABLE 2 | Smaller plasmids and their distribution in clinical (n = 123) and
commensal (n = 46) isolates.






pSHaeA S. haemolyticus 2,300 bp fosB (fosfomycin
resistance)
26.8 8.7









pWBG1773 S. aureus 2,916 bp 25.2 28.3
pKH21 S. aureus 2,531 bp Lincosamin
resistance
5.7 4.3
pWBG754 S. aureus 2,241 bp qacC 29.3 17.4
pC221 S. aureus 4,555 bp Chloramphenicol
resistance
31.7 0





















pSE-12228-05 S. epidermidis Penicillinase
repressor
94.3 45.7
pWBG753 S. aureus blaZ 91.9 43.5
VRSAp S. aureus aacA-aphD 85.3 4.3
VRSAp S. aureus qacA/B 69.1 73.9
VRSAp S. aureus qacR 67.5 76.1













phage, we could identify the first 145 genes in the same order as
in the reference phage.
We identified a large number of IS elements, ranging from
15 to 88 per each isolate. ISSha1 and IS1272 were found
as several copies in all isolates. IS256 was found almost
exclusively in clinical isolates (106/123; 86%) and rarely (5/46;
11%) in commensal isolates. The transposon Tn552/IS481 was
also identified predominantly in clinical isolates (89/123; 72%)
compared to commensal isolates (6/46; 13%).
Biofilm Production and Biofilm Encoding
Genes
Phenotypic biofilm production was significantly more prevalent
among clinical isolates (83/123; 67%) versus commensal isolates
Frontiers in Microbiology | www.frontiersin.org 6 September 2019 | Volume 10 | Article 2096
fmicb-10-02096 September 9, 2019 Time: 16:24 # 7
Pain et al. Genetic Signatures of Staphylococcus haemolyticus
(16/46; 35%), p < 0.001. However, we did not detect ica genes
which typically encode biofilm production in other CoNS species.
Putative Surface Proteins
The C-terminal part of a hypothetical serine-rich surface protein
(SH0326) named sraP (serine rich adhesin for platelets) was
present in 119/123 (97%) of the clinical isolates and in 22/46
(48%) of commensal isolates. The partial sraP gene was located
up-streams of secY2, the first gene in the accessory sec system
(aSec); a structure dedicated to transport and modification of this
surface protein. The N-terminal was located on a different contig
which was, in most cases, correctly assembled directly upstream
of the aSec contig. The central part of SraP, known to contain long
stretches of repeated patterns was lost during assembly. Mapping
sequence reads on assemblies of isolates, predicted to contain
sraP, against the full length SH0326 showed that these strains
did indeed have the full sequence. However, there appeared to be
individual differences in the length of these repeat sequences. The
complete aSec operon was identified in 119 clinical isolates (97%)
and 34 (74%) of commensal isolates by performing sequence
read mapping. Isolates without sraP and aSec belonged to the
commensal clades D (12 isolates) and F (3 isolates), and one
commensal isolate in clade B.
Putative Capsule Polysaccharide (CP)
Operons
We identified four different structures of the CP operons
among the 169 isolates. Seventeen isolates, all of clinical origin,
had the capA-M operon structure similar to that described in
S. haemolyticus JCSC 1435 (Takeuchi et al., 2005). Another
52 isolates had three potential novel CP operons (Figure 4).
These three novel CP operons were homologs to the capA-G
of S. haemolyticus JCSC 1435 (65–100% CDS identity). Each
novel CP operon contained a capH-K region unique to its group,
followed by the region capMII-P (CDS 51–78% identity) which
was common to all the three novel versions. The last gene in the
operon, named capM in JCSC1435 was present in all four CP
operon versions. capM identified in the three novel versions were
named capMII to distinguish it from the already annotated capM
found in JCSC 1435. capL-MII shared homology with S. aureus
cap5/8. The novel CP version 1 was lacking the capH gene and
capI-K did not show considerable homology to any other known
CP genes. However, the novel CP version 2 capH-K showed
homology to S. aureus cap8 (CDS 55–72% identity) and novel CP
version 3 to S. aureus cap5 (CDS 57–68% identity).
Genes and MGE Significantly Different
Between Clinical and Commensal
Isolates
In order to identify a specific signature in the gene repertoire
of the clinical isolates important for hospital adaptation, a
pan-GWAS analysis was performed on the accessory genome.
1887 predicted genes were statistically different between the
two groups (p < 0.05), and the genes found most enriched
for each group are listed in Tables 1, 2. As the population
of S. haemolyticus is diverse, the gene sequence of genes with
the same function varied significantly between the isolates,
resulting in several orthologs clusters for one gene. Two enzymes
in the folate pathway, dihydropteroate synthase (folP) and
dihydroneopterin aldolase (folB) are a representative example of
this. One version was only present in clinical isolates (96/123
isolates, 78%), and not found in any commensal isolates.
FIGURE 4 | Organization of the different polysaccharide capsules (CP) operons identified in our collection. (A) The three novel varies in their homology to the CP in
JCSC1435. capA-G is homologs among all isolates with identified capsule operon. The region capH-K is what separates the four types from one another; novel 1
with no known homology, novel 2 shows homology to S. aureus cap8 and novel 3 with homology to S. aureus cap5. The region capL-P is homologs to S. aureus
and is found in all three novel types, a region absent in JSCS1435. (B) Pie chart showing the distribution of all identified CP operons in this study.
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A different version was found in all 46 commensal isolates, and
27/123 (22%) of clinical isolates. The majority of the clinical
isolates of the latter group belonged to the commensal clade
D and F (19 isolates), with 8 isolates scattered amongst clade
A, B and E. Extracting these CDSs from each isolate and
aligning them displays conserved differences between the genes
in the two groups.
The most prevalent genes with a known function enriched
in the clinical isolates included several ARGs (Table 1). The
most prevalent genes with a known function enriched in the
commensal isolates included several genes involved in metal
control, transposases, and generally different versions of genes
found in clinical isolates (Table 4). Using scores including one or
more ARGs and phenotypic biofilm formation resulted in ROC
curves with area under the curve (AUC) values >0.9, indicating a
high discriminatory capacity to differentiate between clinical and
commensal isolates (Figure 5).
DISCUSSION
There is a significant lack of knowledge about S. haemolyticus
pathogenicity. In the present comparative genome study of
clinical and commensal isolates we identified several genetic
determinants and genotypes associated with the pathogenicity
and the success of S. haemolyticus in the hospital environment.
Resistance to commonly used antimicrobial agents and
disinfectants, in addition to genes encoding proteins involved in
adhesion and human immune defense escape predominates in
the clinical isolates.
Population Structure – Distinct
Signatures of Clinical and Commensal
Isolates
The establishment of hospital adapted S. haemolyticus clones was
previously reported by our group (Cavanagh et al., 2014). In
the current study the majority of the clinical and commensal
isolates form distinct phylogenetic groups when phylogeny is
reconstructed based on SNPs in the core genome. In clades
where clinical isolates are grouped with commensal isolates,
they display a signature more similar to the commensals. In
S. epidermidis there has been more research on phylogenetic
relationship between clinical isolates, but data reported are
conflicting. Conlan et al. (2012) showed that commensal and
invasive isolates were grouped as distinct groups. In contrast,
Méric et al. (2018) recently demonstrated that pathogenic clones
of S. epidermidis can arise from various commensal backgrounds.
This was shown by the absence of specific disease associated
clades in a comparative study of invasive and commensal isolates.
Staphylococcus haemolyticus and S. epidermidis are the two
most recovered CoNS species from infection. Abundance of
S. epidermidis on skin enhances the probability of contamination
of indwelling devices. While S. haemolyticus also is a skin
commensal, the population structure observed among our
isolates suggests that specific persistent hospital adapted clones of
TABLE 4 | Genes and gene versions enriched in 46 commensal isolates, sorted by significance.
Gene name SH_ref Annotation Clinical (%) Commensal (%)
folBX SH2495 Dihydroneopterin aldolase 22.0 100.0
folPX SH2496 Dihydropteroate synthase 23.6 100.0
group_2286 Major Facilitator (MFS) 0.0 56.5
csoR Copper-sensing transcriptional repressor
CsoR
8.1 76.1
copZ Copper chaperone CopZ 8.1 73.9
copA Copper-exporting P-type ATPase 8.1 71.7
czcD Cadmium, cobalt and zinc/H(+)-K(+)
antiporter
8.1 71.7
NAX SH0287 Caax amino terminal protease family protein 4.1 63.0
arsR ArsR family transcpriptional regulator 4.1 63.0
ISSha1X SH2073 Transposase 0.0 47.8
grxC Glutaredoxin 8.1 69.6
nikAX SH0292 Nickel-binding periplasmic protein 4.1 60.9
ydaFX SH2658 Putative ribosomal N-acetyltransferase
YdaF
7.3 65.2
recQ SH1430 ATP-dependent DNA helicase RecQ 44.7 100.0
ansAX SH1433 Putative L-asparaginase 45.5 100.0
IS30 IS30 family transposase 1.6 47.8
yjaB Putative N-acetyltransferase YjaB 2.4 50.0
group_1785 Putative Insertion element/transposase 2.4 50.0
IS1272X SH2041 IS1272 0.0 39.1
yodJ X SH0186 Putative carboxypeptidase YodJ 2.4 47.8
All these genes/gene versions were significantly enriched in commensal isolates (p < 0.001), the order of presentation from top of the table indicates those with the lowest
p values. X These genes exist in different conserved versions in the clinical and commensal isolates. SH_ref; S. haemolyticus reference gene numbers from Takeuchi et al.
(2005), accession number AP006716.1. The complete list of genes can be found in Supplementary Data S2.
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FIGURE 5 | (A–C) Receiver operating characteristics (ROC) curves with area under curve (95% confidence interval) for scores using different combinations of
aacA-aphD, mecA, folP and phenotypic biofilm production in order to discriminate between clinical and commensal isolates.
S. haemolyticus are the major sources of infections, and that skin
contamination is less likely (Tognetti et al., 2012; Kaspar et al.,
2016; Byrd et al., 2018).
Surveillance and molecular typing are important in order
to monitor the epidemiology of established and developing
S. haemolyticus hospital clones. The availability of online
resources, such as PubMLST4, Enterobase5, and BacWGSTdb6,
for bacterial typing offers rapid classification and source tracing,
which is increasingly important in a globalized community
(Ruan and Feng, 2016; Alikhan et al., 2018; Jolley et al.,
2018; Ruan et al., 2019). Currently, it is possible to investigate
S. haemolyticus epidemiology using the traditional MLST
database7, but extended MLST schemes are unavailable. As
S. haemolyticus is an emerging nosocomial pathogen with
extended antibiotic resistance, an online resource offering
rapid typing and phylogenetic relatedness linked to antibiotic
resistance genes and clinical data would be very useful.
The accessory gene repertoire of the clinical isolates is
characterized by high prevalence of ARGs. This was expected
as S. haemolyticus infections are commonly caused by MDR
isolates (Barros et al., 2012; Chang et al., 2018). Creating a
score with ARGs and phenotypic biofilm formation clearly
separated the invasive from the commensal isolates. This can
be useful in clinical microbiology when conveying results of a
positive S. haemolyticus culture back to the treating clinician.
Biofilm forming S. haemolyticus isolates that are resistant to
oxacillin (mecA) and aminoglycosides (aacA-aphD) are most
likely invasive isolates whereas absence of these traits strongly
indicates a commensal isolate.
The interpretation of the folB/folP results is complex. We
found distinct conserved differences in folB and folP clearly
separating clinical from commensal S. haemolyticus isolates.
In S. aureus five mutations in folP have been shown to
directly contribute to sulfonamide resistance (Griffith et al.,
2018). Combination treatment of trimetoprim-sulfamethoxazole
has been used in infections caused by methicillin resistant
staphylococci, and the rates of trimetoprim-sulfamethoxazole





two versions of folP that we identified in our S. haemolyticus
collection had the mutations shown to increase resistance
to sulfonamides in S. aureus. However, there is substantial
sequence variations between the S. haemolyticus and S. aureus
folB and folP genes, and other mutations could also lead to
decreased susceptibility. The importance of the folP versions in
S. haemolyticus needs further evaluation, and extensive testing on
sulfonamide resistance is needed.
In the successful epidemic S. aureus EMRSA-15, mecA
acquisition, mutations in gyrA and glrA; resulting in
fluoroquinolone resistance, and uptake of plasmids carrying
ermC, was shown to be strong drivers of evolution (Holden
et al., 2013). Uptake of plasmid pSHaeB carrying ermC was
only observed for the clinical S. haemolyticus isolates, and has
also been shown to be prevalent in several clinically important
staphylococcal species (Águila-Arcos et al., 2017). The observed
population structure in S. haemolyticus appears more similar to
S. aureus than to S. epidermidis. In S. aureus defined pathogenic
clones have adapted to the specific challenges of the hospital
environment (Rasmussen et al., 2013), and our data support that
similar phenomenon occurs in S. haemolyticus.
IS256, found in the majority of clinical S. haemolyticus isolates,
has also been reported to be more common in nosocomial
isolates of S. epidermidis, and has been associated with gentamicin
resistance due to co-localization on the transposon Tn4001, in
addition to biofilm formation (Kozitskaya et al., 2004; Conlan
et al., 2012; Sharma et al., 2018). IS256 can shape the genome
by affecting gene expression. In several successful virulent MRSA
STs, such as ST 247, the presence of IS256 has been linked
to increased virulence, vancomycin resistance and formation of
small-colony variants (Kleinert et al., 2017). The opposite was
demonstrated in Brazilian MRSA ST 239 isolates where IS256
was integrated near global regulatory genes (agr and mgr) likely
leading to rapid changes of bacterial traits, resulting in reduced
virulence (Botelho et al., 2019). IS256 has been suggested as a
marker for molecular typing and identification of nosocomial,
invasive S. epidermidis isolates (Gu et al., 2005; Yao et al., 2005;
Montanaro et al., 2007). There is also some evidence indicating
that IS256 is not only enriched within invasive isolates, but
also more prevalent in isolates with poor treatment outcome
(Post et al., 2017).
The transposon Tn552/IS481, was also predominantly
identified in clinical S. haemolyticus isolates, and this MGE often
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carry antiseptic resistance and beta lactamase genes (Anthonisen
et al., 2002). The pandemic S. aureus ST239 has acquired
resistance to multiple antibiotics and antiseptics, among them
qac A and B (Chang et al., 2017). Qac proteins are efflux pumps
that protect bacteria not only from a variety of toxic substances
but also from fluorquinolones and beta-lactams (Prag et al.,
2014; Wassenaar et al., 2015; Taheri et al., 2016). In our study,
qacA was detected more often in clinical isolates, while qacB
was almost exclusive to the commensal isolates. qacA has been
reported to have a broader spectrum of resistance than qacB, and
this might be the reason why we found qacA more often in the
clinical samples (in 65% clinical isolates and 39% commensal
isolates), obtained from an environment with higher antibiotic
pressure (Wassenaar et al., 2015).
The Adhesion Protein SraP Is Highly
Prevalent in Clinical Isolate
In the clinical isolates we commonly identified a homolog
(SH0326) of the serine-rich repeat glycoproteins SraP of S. aureus
and the accessory sec system, dedicated for the export of SraP.
SraP belongs to a highly conserved family of serine-rich surface
glycoproteins of Gram-positive bacteria. Expression of SraP has
been linked to adhesion to different types of cells, including
human platelets and is associated with infective endocarditis
(Siboo et al., 2005; Yang et al., 2014; Bensing et al., 2016).
The higher prevalence of the aSec system and sraP is likely
advantageous for the clinical S. haemolyticus isolates as they
are mainly isolated from blood. In S. epidermidis, genome
signatures linked to pathogenicity identified the aSec gene asp3
as one of four strong virulence predictors. In their full list of
pathogenicity-associated signature genes sraP was also identified
(Méric et al., 2018).
A Novel Capsular Polysaccharide Operon
The polysaccharide capsule (CP) in S. haemolyticus has been
shown to play a role in the protection against uptake and killing
by human neutrophils (Flahaut et al., 2008). In S. aureus it
was demonstrated to modulate adherence to endothelial surfaces
in vitro, and to promote bacterial colonization and persistence on
mucosal surfaces in animal models (Riordan and Lee, 2004).
In this study we found four different capsule operons of
which only the first type has been described in S. haemolyticus
JCSC1435 previously (Takeuchi et al., 2005). Two of the three
novel CP (capNOP) structures have homology to the S. aureus
cap 5/8 genes, and identification of capO in S. haemolyticus has
not previously been reported. The third type has no homology
to any previously described cap version. The new CP versions in
S. haemolyticus have a variable region, capH-K which is unique
to each of the four versions with little or no homology between
them. The GC content of this variable region is also significantly
lower than the surrounding cap genes, indicating the variable
region was acquired by HGT. Both CP genes and SCC are
located in the oriC environ, a region of high genomic flexibility,
allowing staphylococci to maintain or acquire genes needed for
the adaption to on-going environmental changes (Hiramatsu
et al., 2014). The new CP structures were mainly found in isolates
belonging to two clinical clades. The four different CP types
were shown to be clade specific, which has also been shown for
S. aureus. In S. aureus 13 putative capsular operons have been
reported, but only CP type 5 and 8 have been associated with
disease (Mohamed et al., 2019), thus the three novel CP types
now identified in S. haemolyticus need to be further investigated
for their role in virulence.
Taken together, our findings point toward HGT as a driving
force in S. haemolyticus evolution and in response to the selective
pressure of broad-spectrum antibiotics used in hospitals.
The S. haemolyticus Pan-Genome
Distribution Reflects the High Variation
of Commensal Isolates
The pan-genome analysis reflected a relatively stable core genome
which is comparable to what is observed in S. epidermidis,
S. aureus and Staphylococcus lugdunensis. In S. haemolyticus the
core genome is slightly smaller which could be explained by the
higher number of unique genes in the commensal isolates (Méric
et al., 2015, 2018; Argemi et al., 2018). Similar to S. haemolyticus,
S. aureus and S. epidermidis also have an open pan-genome in
contrast to S. lugdunensis (Bosi et al., 2016; Argemi et al., 2018).
However, the pan-genome accumulation curves for S. epidermidis
and S. aureus are not as steep as we see for S. haemolyticus
(Conlan et al., 2012; Méric et al., 2015; Sharma et al., 2018).
The relatively large pan-genome of S. haemolyticus is, at least in
part, due to the variation seen in genes of the same function,
resulting in two or more clusters for one gene. The most
abundant categories in the core genome were genes involved in
housekeeping functions, like transcription and translation, and
different metabolism categories, a result similar to reports on
S. aureus and S. epidermidis (Bosi et al., 2016; Sharma et al., 2018).
The large repertoire of genes in the accessory genome confer
advantages in highly variable environmental conditions.
Strengths and Limitation With the Study
This study is the largest comparative study of clinical and
commensal S. haemolyticus isolates to date, and the clinical
isolates have wide spatial and temporal distribution. We have
used state of the art technology to analyze pathogenicity traits and
the genetic signatures of clinical and invasive isolates. The study
also has limitations. First, the majority of the commensal isolates
are from one geographic location, and more recently collected
than the invasive isolates. Still, the very diverse commensal
population indicates that commensal isolates may lack the
pathogenic traits of hospital-adapted clones. Second, the invasive
isolates are collected over a wide time-span and some of the
isolates originated from infections two decades ago. Still we
see a very clear phylogenetic clustering, and invasive isolates
from different geographical origin cluster together. We believe
this clearly indicates the emergence of disease-causing isolates
with a homogenous genetic signature. Third, it would have been
of interest to collect skin samples from hospitalized patients
without infection, in order to see whether colonization of more
pathogenic isolates emerges after hospitalization. We did not
have the opportunity to collect such samples in this study, but we
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will pursue this in the future. Finally, we do not know whether
some of the clonal groups are still circulating or might have
been replaced by new clones. This phenomenon was observed
in S. aureus where the pandemic clone ST239-MRSA-III that
circulated for several decades (Monecke et al., 2018) was replaced
with clones with increased fitness (Hsu et al., 2015). Still, we
believe that our current study has identified important features of
hospital adapted S. haemolyticus clones. Future sampling of both
commensal and invasive isolates is needed in order to monitor
the evolution of S. haemolyticus.
CONCLUSION
In this study we have gained a deeper understanding of the
mechanism of adaption of S. haemolyticus in the hospital
environment by phylogenetic and pan-genome analysis. We
have found a clear segregation of isolates of commensal
origin, and specific genetic signatures distinguishing the clinical
isolates from the commensal isolates. It is highly likely that
the widespread use of antimicrobial agents has promoted the
development of MDR clones of S. haemolyticus persisting
in the hospital environment, and that these isolates have
responded through acquisition of mobile genetic elements
or beneficial point mutations and rearrangements in surface
associated genes. Defining pathogen-associated signatures is an
important step in infection control. Continuous surveillance
and molecular typing are important in order to monitor
the spread and evolution of the S. haemolyticus hospital
clones in the future.
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